FDA
approval
· 2017-05-30
FDA Approved: ATOMOXETINE HYDROCHLORIDE — Original Application (Apotex Corp.)
Summary
FDA approved Apotex Corp.'s generic atomoxetine hydrochloride as an original ANDA for the treatment of attention-deficit/hyperactivity disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ATOMOXETINE HYDROCHLORIDE (ATOMOXETINE HYDROCHLORIDE)